Best GLP-1 programs for PCOS
Compare GLP-1 care, costs and our PCOS suitability scores.
Advertising disclosure. We earn commissions from some links, at no extra cost to you. How we’re funded
Top programs on PCOS & hormonal suitability
Order follows the published PCOS & hormonal suitability score, with no partner boost. Featured placements above are paid and separate.
- 92PCOSView plan
1.Allara Health
Highest PCOS scoreOverall Luna Fit 83/100
Medication prices & plan terms below.Details & terms - 90PCOSView plan
Overall Luna Fit 93/100
Semaglutide: Starting at $79/moTirzepatide: Starting at $129/moDetails & terms - 90PCOSView plan
Overall Luna Fit 86/100
Medication prices & plan terms below.Details & terms - 89PCOSView plan
Overall Luna Fit 86/100
Medication prices & plan terms below.Details & terms - 89PCOSView plan
Overall Luna Fit 77/100
Medication prices & plan terms below.Details & terms - 89PCOSView plan
Overall Luna Fit 77/100
Medication prices & plan terms below.Details & terms - 88PCOSView plan
Overall Luna Fit 86/100
Medication prices & plan terms below.Details & terms - 88PCOSView plan
Overall Luna Fit 83/100
Medication prices & plan terms below.Details & terms - 88PCOSView plan
Overall Luna Fit 83/100
Medication prices & plan terms below.Details & terms - 88PCOSView plan
Overall Luna Fit 82/100
Medication prices & plan terms below.Details & terms
Full prices & plan conditions
Starting prices, introductory offers and prepaid equivalents describe different purchases. Read each provider’s full terms before comparing the amount you will pay.
Allara Health
Semaglutide: Not published per drug — brand Wegovy (pen or pill) and Ozempic are prescribed and billed through your pharmacy and insurance or paid out of pocket; its own compounded semaglutide is cash-only with no price shown before signup. Self-pay care membership is $149/mo month-to-month, medication billed separately; a weight-loss page quotes GLP-1 care from $154/mo for the first three months without naming the drug
Tirzepatide: Not published per drug — brand Zepbound (vial or pen) and Mounjaro are prescribed and billed through your pharmacy and insurance or paid out of pocket; its own compounded tirzepatide is cash-only with no price shown before signup. Self-pay care membership is $149/mo month-to-month, medication billed separately
Midi Health
Semaglutide: $165.90 per 4-week supply at 0.1–0.5 mg for its compounded "GLP-1" injectable (Midi does not name the molecule), $270.90 at 0.75–1.5 mg, $340 at 1.75–2 mg, $355 at 2.5 mg; sublingual $164–$275; shipping included, no membership fee. Visits billed separately ($250 first / $150 follow-up self-pay, or in-network insurance). Brand-name GLP-1s go to your own pharmacy at your insurance's price
Tirzepatide: $210 per 4-week supply at 1.25–2.5 mg for its compounded "Dual-Action GLP-1/GIP" injectable, $285 at 3.75–6.25 mg, $375 at 7.5–12.5 mg, $434 at 13.75–15 mg; sublingual $209–$460; shipping included, no membership fee. Visits billed separately ($250 first / $150 follow-up self-pay, or in-network insurance)
Eden
Semaglutide: $99/mo at every dose (its terms describe a separate membership)
Tirzepatide: $129/mo at every dose (its terms describe a separate membership)
Live Vital
Semaglutide: ~$128/mo ($299 per 10-week protocol; no monthly rate published)
Tirzepatide: ~$235/mo ($549 per 10-week protocol; no monthly rate published)
NEUVÉ Health
Semaglutide: Standard injection from $219/mo ($189 first month); microdose $179/mo; oral RDT $329/mo — confirm any separate platform fee
Tirzepatide: Standard injection from $349/mo ($299 first month); microdose $240/mo; oral RDT $279/mo — confirm any separate platform fee
Ro
Semaglutide: Brand Wegovy pill from $149/mo (Wegovy pen $199 for two months, then $349) — plus Ro membership $149/mo ($39 first month)
Tirzepatide: Brand Zepbound from $299/mo (KwikPen) — plus Ro membership $149/mo ($39 first month)
Gala Health
Semaglutide: From $199/mo on a 3-month plan per FAQ; separate pages advertise $179/mo on a yearly subscription; brand Ozempic from $1,299/mo
Tirzepatide: From $199/mo per product FAQ; $179/mo advertised on a yearly subscription, with no complete month-to-month ladder
Telos Rx
Semaglutide: Current plan-specific monthly quote required; public oral headline uses a daily prepaid equivalent
Tirzepatide: From $139/mo injectable, plan-length dependent; flexible and oral renewal totals require a quote
Alloy
Semaglutide: From $169/mo all-in ($70 medication + $99 membership)
Tirzepatide: From $199/mo all-in ($100 medication + $99 membership)
Allara Health has the highest published PCOS score at 92/100. Neighboring scores are close; across our scored coverage the range is 55–92. Scores do not establish clinical suitability.
The ranking, provider by provider
Ordered by PCOS & hormonal suitability. Prices are the lowest monthly figure each provider discloses for each molecule; “not disclosed” means exactly that and is never filled in with a guess.
- #1
Luna Fit
83/100Allara Health
PCOS fit 92A PCOS-first women's health practice that pairs one OB-GYN, endocrinologist or nurse practitioner with one dietitian, runs hormone and metabolic labs, takes major insurance, and prescribes brand GLP-1s when they fit.
Best for: A woman with PCOS, insulin resistance, thyroid trouble or perimenopause who wants labs, a steady care team and a dietitian, ideally covered by her insurance.
- Semaglutide:
- Not published per drug — brand Wegovy (pen or pill) and Ozempic are prescribed and billed through your pharmacy and insurance or paid out of pocket; its own compounded semaglutide is cash-only with no price shown before signup. Self-pay care membership is $149/mo month-to-month, medication billed separately; a weight-loss page quotes GLP-1 care from $154/mo for the first three months without naming the drug
- Tirzepatide:
- Not published per drug — brand Zepbound (vial or pen) and Mounjaro are prescribed and billed through your pharmacy and insurance or paid out of pocket; its own compounded tirzepatide is cash-only with no price shown before signup. Self-pay care membership is $149/mo month-to-month, medication billed separately
- States:
- Full medical and nutrition care in 45 states plus D.C. (listed on its own site); nutrition-only in Hawaii, Kansas, New Mexico, Rhode Island and South Carolina
- #2
Luna Fit
93/100CoreAge Rx
PCOS fit 90Compounded semaglutide and tirzepatide on one account, at one posted price that does not rise with your dose — tirzepatide being the option many women with insulin resistance ask about.
Best for: Women who want one flat price at every dose and both semaglutide and tirzepatide from the same program.
- Semaglutide:
- Starting at $79/mo
- Tirzepatide:
- Starting at $129/mo
- States:
- US only; some state limits shown at intake (no list published)
- #3
Luna Fit
86/100Midi Health
PCOS fit 90Both molecules pricedAn insurance-friendly virtual women's health clinic built around perimenopause and menopause, with hormone therapy, labs and GLP-1s (brand-name or compounded) from the same clinician.
Best for: A woman in perimenopause or menopause with PPO insurance who wants hormone therapy, weight care and lab follow-up from a menopause-trained clinician, not a medication-only subscription.
- Semaglutide:
- $165.90 per 4-week supply at 0.1–0.5 mg for its compounded "GLP-1" injectable (Midi does not name the molecule), $270.90 at 0.75–1.5 mg, $340 at 1.75–2 mg, $355 at 2.5 mg; sublingual $164–$275; shipping included, no membership fee. Visits billed separately ($250 first / $150 follow-up self-pay, or in-network insurance). Brand-name GLP-1s go to your own pharmacy at your insurance's price
- Tirzepatide:
- $210 per 4-week supply at 1.25–2.5 mg for its compounded "Dual-Action GLP-1/GIP" injectable, $285 at 3.75–6.25 mg, $375 at 7.5–12.5 mg, $434 at 13.75–15 mg; sublingual $209–$460; shipping included, no membership fee. Visits billed separately ($250 first / $150 follow-up self-pay, or in-network insurance)
- States:
- All 50 states for visits, per its own site; compounded GLP-1s "not available in all 50 states" per its own fine print
- #4
Luna Fit
86/100Eden
PCOS fit 89Both molecules pricedOne posted price in every month and at every dose, $99 for semaglutide and $129 for tirzepatide, plus brand-name prescriptions; read its terms, which describe a separate membership.
Best for: Women who want one flat monthly price at every dose and the option of a brand-name prescription, and who will check the checkout total line by line.
- Semaglutide:
- $99/mo at every dose (its terms describe a separate membership)
- Tirzepatide:
- $129/mo at every dose (its terms describe a separate membership)
- States:
- All 50 states
- #5
Luna Fit
77/100Live Vital
PCOS fit 89A named physician with a published menopause focus and a ten-week GLP-1 protocol; compare the $299/$549 protocol totals, not the monthly-looking headlines.
Best for: Women in perimenopause who want a named, menopause-credentialled physician rather than a clinician network, and who will do the arithmetic on the protocol price themselves.
- Semaglutide:
- ~$128/mo ($299 per 10-week protocol; no monthly rate published)
- Tirzepatide:
- ~$235/mo ($549 per 10-week protocol; no monthly rate published)
- States:
- Publishes all 50 states for general care; testosterone programs limited to 34 states
- #6
Luna Fit
77/100NEUVÉ Health
PCOS fit 89Visible weight, hormone and laboratory menus; current treatment prices include prescribed medication and clinician review, while separate platform-fee language still needs clarification.
Best for: Women who value adjacent hormone and laboratory options and will request an itemized treatment and platform quote.
- Semaglutide:
- Standard injection from $219/mo ($189 first month); microdose $179/mo; oral RDT $329/mo — confirm any separate platform fee
- Tirzepatide:
- Standard injection from $349/mo ($299 first month); microdose $240/mo; oral RDT $279/mo — confirm any separate platform fee
- States:
- Availability varies by state, service, provider and clinical eligibility
- #7
Luna Fit
86/100Ro
PCOS fit 88A large platform built on brand-name Wegovy, Zepbound and Foundayo with insurance help, and published cash prices; the membership and the medication are billed separately.
Best for: Women who want brand-name medication and insurance support, and are comfortable with a big, polished platform.
- Semaglutide:
- Brand Wegovy pill from $149/mo (Wegovy pen $199 for two months, then $349) — plus Ro membership $149/mo ($39 first month)
- Tirzepatide:
- Brand Zepbound from $299/mo (KwikPen) — plus Ro membership $149/mo ($39 first month)
- States:
- Multi-state
- #8
Luna Fit
83/100Gala Health
PCOS fit 88A GLP-1 program built explicitly for women — its product pages say so, and it sells HRT and menopause care beside the weight-loss line, which is a genuine draw if you are managing metabolism and hormones together. The $179 entry is real, but it is a yearly-subscription rate; no month-to-month price is published.
Best for: Women who want compounded tirzepatide and hormone care from one provider, are comfortable committing to a year to get the advertised rate, and value having a brand-Ozempic escape hatch.
- Semaglutide:
- From $199/mo on a 3-month plan per FAQ; separate pages advertise $179/mo on a yearly subscription; brand Ozempic from $1,299/mo
- Tirzepatide:
- From $199/mo per product FAQ; $179/mo advertised on a yearly subscription, with no complete month-to-month ladder
- States:
- All 50 states
- #9
Luna Fit
83/100Telos Rx
PCOS fit 88A broad GLP-1 and women’s HRT catalog with named pharmacies, but incomplete public price totals and conflicting lab-cost language.
Best for: Women comparing several routes and separate HRT who will obtain a complete written treatment and billing plan.
- Semaglutide:
- Current plan-specific monthly quote required; public oral headline uses a daily prepaid equivalent
- Tirzepatide:
- From $139/mo injectable, plan-length dependent; flexible and oral renewal totals require a quote
- States:
- All 50 states claimed; product and pharmacy restrictions vary
- #10
Luna Fit
82/100Alloy
PCOS fit 88Midlife-focused physician care with menopause treatments alongside GLP-1 options; add the $99 care membership to every medication starting price.
Best for: Women in perimenopause or menopause who value an ongoing physician relationship and can budget for care plus medication.
- Semaglutide:
- From $169/mo all-in ($70 medication + $99 membership)
- Tirzepatide:
- From $199/mo all-in ($100 medication + $99 membership)
- States:
- Not disclosed; compounded excluded in 6 states and DC
Showing the top 10 of 88. The rest of the field is on the main ranking, or compare any two head-to-head.
What “PCOS & hormonal suitability” actually measures
It is one of the six factors behind every Luna Fit Score, and it is our editorial judgment — not a provider's claim about itself, and not a clinical rating of a drug. Broadly it asks whether a general GLP-1 program can hold the parts of PCOS care that go beyond a prescription:
- Access to both molecules. Tirzepatide is frequently the one asked about where insulin resistance drives the weight, so a semaglutide-only menu is a real limitation — see semaglutide vs tirzepatide for women.
- Labs and monitoring as part of the plan, not an upsell. What is worth measuring, and when, is in GLP-1 labs and monitoring for women.
- Whether hormonal context is handled at all — cycles, androgens, contraception timing around a slowed gut. Background in GLP-1s and insulin resistance and GLP-1s and birth control.
- Continuity. PCOS is managed over years, so cancellation terms and ongoing support matter more than a first-month price. How we weigh all six factors is set out in our published methodology.
The score alone does not establish specialist qualifications or make a medicine appropriate for you. Read each provider’s review for its specific care model and confirm the clinician’s qualifications before booking.
GLP-1s and PCOS, answered
- Is Ozempic or semaglutide approved for PCOS?
- No. No GLP-1 medicine — semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) — is FDA-approved to treat polycystic ovary syndrome. Prescribing one for PCOS is off-label: legal, common, and a prescriber's clinical judgment, but not an approved indication, and not something any telehealth provider can change. Approvals for these drugs are for type 2 diabetes and for weight management in people who meet the criteria; many women with PCOS qualify on the weight-management route rather than on a PCOS diagnosis.
- Which GLP-1 provider is best for PCOS?
- On our published PCOS & hormonal suitability score, Allara Health scores highest here, at 92/100. That score is our editorial judgment of how well a general GLP-1 program suits someone managing PCOS — whether both molecules are available, whether labs and monitoring are part of the plan, whether hormonal context is handled at all. It is not a finding that any provider specializes in PCOS. Across all 88 providers we score, the factor runs from 92 down to 55, so the leading options sit in a narrow band rather than behind one runaway winner.
- Semaglutide or tirzepatide for PCOS — does it matter?
- Insulin resistance is a central driver for most women with PCOS, which is why tirzepatide — a dual GIP/GLP-1 agonist — comes up so often in this conversation. Practically, it means a provider that only prices semaglutide cannot offer that path at all. Of the 10 providers here, 2 publish a price for both molecules. Neither drug is approved for PCOS, and which one suits you is a clinical decision, not a shopping one.
- How is this different from your best GLP-1 for women page?
- The women's page is the broad hub: it ranks the same providers on the whole Luna Fit Score, covering perimenopause, contraception, labs and general fit. This page narrows to one published factor — PCOS and hormonal suitability — and ranks on that alone, with no partner edge applied to the order. Start on the women's hub if you are weighing GLP-1 care generally; stay here if PCOS is the reason you are looking.
- What about metformin or inositol — do I still need those?
- That is a question for your prescriber, not a page like this one. Metformin has a long history in PCOS care and inositol is widely used, and neither is displaced by a GLP-1 simply because a GLP-1 produces more weight loss. What matters here is that a provider is willing to look at your whole picture — labs, cycle, androgens, existing medications — rather than write a prescription and move on. That willingness is a large part of what the suitability score is judging.
Keep reading: what the evidence shows on GLP-1s and PCOS, how to choose a provider, what it costs and how to start safely, or perimenopause and menopause if that is also in the picture.
This page is informational and not medical advice. GLP-1 medicines are not FDA-approved for PCOS and any such use is off-label; compounded medications are not FDA-approved brand products. Do not use these medicines in pregnancy or while trying to conceive. See our medical disclaimer.
For a cost-first comparison, our month-to-month GLP-1 guide keeps ongoing injection prices separate from starting offers. If you prefer an FDA-approved product, explore programs with a brand-name medication pathway; availability and coverage still need to be confirmed.
Our provider recommendation hub explains which comparison suits each decision.
This is the PCOS-specific page. The broad women's hub is best GLP-1 for women; what the research shows is GLP-1 medication and PCOS.